MyAverix Finance
F · Healthcare
LONZA GROUP UNSP.ADR 1/10 (LO3A)
Diagnostics & Research
LONZA GROUP UNSP.ADR 1/10 (LO3A) is listed on F in the Healthcare sector. Industry: Diagnostics & Research. As of 2026-03-30, reported market cap is $37.18B, P/E ratio is 37.32, net margin is 14.5%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for LO3A
LONZA GROUP UNSP.ADR 1/10 (LO3A) — FAQ
What is LONZA GROUP UNSP.ADR 1/10's market cap?
LONZA GROUP UNSP.ADR 1/10 (LO3A) has a reported market cap of $37.18B (data as of 2026-03-30).
What is LO3A's P/E ratio?
The price-to-earnings (P/E) ratio for LONZA GROUP UNSP.ADR 1/10 (LO3A) is 37.32 (data as of 2026-03-30).
Does LONZA GROUP UNSP.ADR 1/10 pay a dividend?
Dividend yield is not available in the current snapshot for LONZA GROUP UNSP.ADR 1/10 (LO3A). Check the MyAverix Finance app for the latest dividend data.
What sector is LONZA GROUP UNSP.ADR 1/10 in?
LONZA GROUP UNSP.ADR 1/10 (LO3A) is classified in the Healthcare sector (Diagnostics & Research industry).
What exchange is LO3A listed on?
LO3A is listed on F.
What is LONZA GROUP UNSP.ADR 1/10's net margin?
LONZA GROUP UNSP.ADR 1/10 (LO3A) reports a net margin of 14.5% (data as of 2026-03-30).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.